Competing interests in development of clinical practice guidelines for diabetes management: Report from a multidisciplinary workshop
Anna M Sawka1, Lilian Magalhães2, Amiram Gafni3,4, Gary F Lewis1
1Division of Endocrinology, Department of Medicine, University Health Network and University of Toronto, Toronto, Ontario, Canada; 2School of Occupational Therapy, University of Western Ontario, London, Ontario, Canada; 3Department of Clinical Epidemiology and Biostatistics, McMaster University, Hamilton, Ontario, Canada; 4Centre for Health Economics and Policy Analysis, Hamilton, Ontario, Canada
Objective: To explore the complex issue of competing interests (CIs) in development of clinical practice guidelines (CPGs) in diabetes with stakeholders.
Methods: A multidisciplinary panel of 26 health, methodological, legal, and bioethical experts, trainees, and lay people from across Canada participated in a workshop on CIs in CPGs. Mixed methods were used such that qualitative themes were extracted from the discussions and quantitative survey data were collected.
Results: In the discussions, participants acknowledged that potential competing interests were not uncommon among sponsoring organizations and authors of CPGs. Avoidance of all potential CIs in development of CPGs was emulated as ideal, but considered probably unrealistic, given the paucity of peer-reviewed funding opportunities for development of evidence-informed CPGs and the scarcity of knowledgeable authors without CIs. An optimal approach for management of CIs in CPGs could not be agreed upon by participants. Full disclosure of any financial CIs for authors and sponsoring organizations as well as discouragement of external financial contributors from writing involvement, were endorsed by participants in the workshop and a subsequent survey.
Conclusions: Complete disclosure of financial CIs of sponsoring organizations and authors of CPGs is essential, yet the optimal approach to management of potential CIs is currently undefined.
Keywords: conflicts of interest, clinical practice guidelines, diabetes, knowledge translation, bioethics
This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.Download Article [PDF]
Readers of this article also read:
Chan NC, Bhagirath V, Eikelboom JW
Published Date: 26 June 2015
A critical appraisal of ibrutinib in the treatment of mantle cell lymphoma and chronic lymphocytic leukemia
Tucker DL, Rule SA
Published Date: 23 June 2015
Prolonged increase in tear meniscus height by 3% diquafosol ophthalmic solution in eyes with contact lenses
Nagahara Y, Koh S, Nishida K, Watanabe H
Published Date: 9 June 2015
Nocerino N, Fulgione A, Iannaccone M, Tomasetta L, Ianniello F, Martora F, Lelli M, Roveri N, Capuano F, Capparelli R
Published Date: 5 March 2014
Radiofrequency-targeted vertebral augmentation versus traditional balloon kyphoplasty: radiographic and morphologic outcomes of an ex vivo biomechanical pilot study [Erratum]
Published Date: 5 June 2013
Long-term tolerability of topical diclofenac sodium 1% gel for osteoarthritis in seniors and patients with comorbidities
Peniston JH, Gold MS, Wieman MS, Alwine LK
Published Date: 20 November 2012
Jantus-Lewintre E, Usó M, Sanmartín E, Camps C
Published Date: 12 June 2012
Effects of 4:1 carbohydrate/protein solution versus a carbohydrate-alone solution on IL-6, TNF-α, and cortisol during prolonged cycling in hot environmental conditions
Cosio-Lima LM, Desai B, Stelzer JW, Schuler PB
Published Date: 15 March 2012
Mila Petrova, Zhasmina Mihaylova, Albena Fakirova
Published Date: 27 May 2010
Published Date: 12 January 2009